Aurinia Pharmaceuticals Inc AUPH
16.44
(0.16)
(0.96%)
as of 25 Sep
- Market cap
- $2.2B
- P/E
- 6.9×
Follow AUPH
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 199.56 | 7.35 |
P/S ratio |
438.51 | 892.47 | 1,248.84 | 5,926.62 | 32.69 | 64.88 | 6.29 | 7.13 | 5.46 | 7.57 |
P/FCF ratio |
6.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.13 | 15.83 |
P/Operating CF |
(17.81) | (41.77) | (42.47) | (74.18) | 511.39 | (114.14) | 80.67 | 87.47 | 42.66 | 46.93 |
P/B ratio |
2.11 | 2.25 | 5.14 | 6.31 | 4.02 | 6.18 | 2.08 | 3.31 | 3.40 | 3.69 |
Price to Tangible BV |
3.72 | 2.46 | 5.78 | 6.50 | 4.11 | 6.29 | 2.11 | 3.36 | 3.44 | 3.71 |
EV/Sales |
209.33 | 477.49 | 977.01 | 4,965.10 | 24.86 | 54.79 | 3.42 | 5.57 | 4.19 | 6.35 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 94.59 | 13.42 |
EV/Operating CF |
(1.94) | (4.85) | (8.76) | (24.83) | (17.84) | (15.85) | (5.77) | (29.19) | 22.18 | 13.25 |
EV/FCF |
2.92 | (4.85) | (8.75) | (24.79) | (16.52) | (15.81) | (5.75) | (28.58) | 22.33 | 13.27 |
Quick Ratio |
5.01 | 21.30 | 17.36 | 27.13 | 12.47 | 11.85 | 8.74 | 4.85 | 4.04 | 4.69 |
Current Ratio |
5.22 | 21.50 | 18.30 | 27.90 | 13.11 | 12.63 | 9.60 | 5.50 | 4.57 | 5.25 |
Net Debt/EBITDA |
1.84 | 3.79 | 2.30 | 4.09 | 4.08 | 2.59 | 3.48 | 3.84 | (28.81) | (2.58) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 1.29% | 1.11% | 1.13% | 13.77% | 10.63% | 6.96% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.20 | 0.16 | 0.09 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.09 | 0.26 | 0.34 | 0.43 | 0.43 |
Operating CF/Net income |
0.80 | 0.58 | 0.80 | 0.72 | 0.68 | 0.87 | 0.74 | 0.43 | 7.72 | 0.47 |
Capex/Depreciation |
23.73 | (0.02) | (0.05) | (0.09) | (4.07) | (0.11) | (0.11) | (0.06) | (0.01) | (0.01) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (83.33%) | (70.20%) | (46.08%) | (42.99%) | (29.07%) | (40.81%) | (24.46%) | (19.92%) | 1.52% | 59.91% | |
| (51.44%) | (57.36%) | (38.20%) | (37.60%) | (26.06%) | (35.94%) | (21.33%) | (15.31%) | 1.05% | 44.11% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (395.10%) | (590.76%) | (330.89%) | (50.58%) | (7.28%) | 30.35% |
Return on Tangible Assets |
(69.50%) | (42.36%) | (51.04%) | (29.08%) | (26.18%) | (37.93%) | (27.04%) | (22.23%) | 1.64% | 71.74% |
Average Days of Receivables |
181.45 | 95.18 | 171.07 | 422.39 | 5.84 | 123.37 | 36.72 | 50.10 | 56.73 | 53.46 |
Research and Development Expense of Revenue |
8,401.16% | 8,117.22% | 8,937.80% | 16,624.53% | 100.42% | 112.13% | 33.57% | 28.28% | 8.84% | 11.48% |
Selling, General and Administrative Expense of Revenue |
4,031.21% | 2,893.78% | 2,953.35% | 7,024.53% | 191.51% | 380.52% | 146.51% | 111.12% | 73.16% | 35.96% |
Intangible Assets out of Total Assets |
0.27 | 0.07 | 0.09 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
799.42% | 1,014.83% | 1,481.64% | 2,331.45% | 34.83% | 68.51% | 24.10% | 25.82% | 13.44% | 5.19% |
Graham Net Nets |
0.27 | 0.41 | 0.17 | 0.15 | 0.22 | 0.15 | 0.45 | 0.20 | 0.21 | 0.15 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.63 | 14.53 |
Earnings Yield |
(30.23%) | (23.71%) | (11.00%) | (4.70%) | (5.98%) | (6.17%) | (12.79%) | (6.18%) | 0.50% | 13.61% |
Free Cash Flow Yield |
16.34% | (11.04%) | (8.94%) | (3.38%) | (4.60%) | (5.34%) | (9.47%) | (2.73%) | 3.43% | 6.32% |
Revenue per Share |
0.00 | 0.01 | 0.01 | 0.00 | 0.42 | 0.35 | 0.94 | 1.23 | 1.64 | 2.11 |
Operating CF per Share |
(0.53) | (0.54) | (0.61) | (0.68) | (0.59) | (1.22) | (0.56) | (0.23) | 0.31 | 1.01 |
Capex per Share |
0.88 | 0.00 | 0.00 | 0.00 | (0.05) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.35 | (0.54) | (0.61) | (0.68) | (0.64) | (1.22) | (0.56) | (0.24) | 0.31 | 1.01 |
Cash per Share |
1.12 | 2.26 | 1.48 | 3.29 | 3.36 | 3.60 | 2.74 | 2.45 | 2.51 | 2.96 |
Shareholders Equity per Share |
1.02 | 2.15 | 1.33 | 3.21 | 3.44 | 3.70 | 2.86 | 2.64 | 2.64 | 4.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.02 | 2.15 | 1.33 | 3.21 | 3.44 | 3.70 | 2.86 | 2.64 | 2.64 | 4.33 |
Free Cash Flow |
12.40 | (41.19) | (51.68) | (63.69) | (75.44) | (157.99) | (79.82) | (34.18) | 44.11 | 135.41 |
Working Capital |
33.49 | 167.10 | 125.59 | 303.84 | 387.43 | 472.68 | 396.43 | 347.61 | 348.83 | 398.24 |
Capital Expenditures |
31.11 | (0.02) | (0.07) | (0.10) | (5.58) | (0.30) | (0.29) | (0.72) | (0.28) | (0.25) |
Net Current Asset Value |
20.37 | 151.15 | 99.56 | 289.44 | 363.52 | 449.05 | 377.11 | 254.69 | 273.43 | 321.71 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.71 |
Capex to Sales |
(179.83) | 0.06 | 0.16 | 0.32 | 0.11 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(13,465.32%) | (16,935.89%) | (13,848.81%) | (27,794.03%) | (204.88%) | (396.81%) | (80.71%) | (44.45%) | 2.45% | 101.47% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.73 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
45.21 | 43.16 | 35.29 | 12.59 | 0.29 | 0.62 | 0.74 | 3.47 | 7.12 | 9.21 |
Cash ROIC |
(24.79%) | (12.15%) | (21.66%) | (10.53%) | (9.19%) | (17.04%) | (10.40%) | (4.58%) | 5.24% | 12.94% |
Accounts Receivable Turnover |
2.60 | 4.29 | 2.84 | 1.09 | 85.70 | 5.62 | 9.28 | 9.34 | 7.76 | 7.26 |
Accounts Payable Turnover |
0.24 | 0.17 | 0.00 | 0.00 | 0.06 | 0.04 | 0.15 | 0.64 | 5.94 | 7.69 |
Inventory Turnover |
0.00 | 0.00 | — | — | 0.08 | 0.07 | 0.26 | 0.44 | 0.72 | 0.77 |
Average Days of Payables |
1,924.15 | 2,492.31 | 0.00 | 0.00 | 8,384.14 | 11,691.71 | 2,577.04 | 111.63 | 67.02 | 37.02 |
Days of Inventory on Hand |
0.00 | 0.00 | — | — | 4,708.87 | 6,465.62 | 1,595.07 | 1,024.34 | 506.88 | 510.54 |
Average Receivables |
0.07 | 0.10 | 0.16 | 0.29 | 0.58 | 8.11 | 14.45 | 18.79 | 30.32 | 39.00 |
Average Payables |
4.56 | 6.88 | 7.52 | 9.12 | 17.99 | 29.87 | 37.47 | 22.16 | 4.76 | 4.25 |
Average Inventory |
— | — | — | — | 13.09 | 16.63 | 22.04 | 32.23 | 39.47 | 42.46 |
Average Assets |
45.28 | 123.42 | 167.86 | 235.08 | 393.98 | 503.51 | 507.11 | 509.46 | 549.35 | 651.12 |
Average Common Equity |
27.96 | 100.85 | 139.16 | 205.59 | 353.18 | 443.42 | 442.26 | 391.69 | 377.72 | 479.40 |
Columns are period end dates